Acutaas Chemicals ACUTAAS
Gujarat specialty chemicals company (pharma intermediates, CDMO) with a fast-growing battery-electrolyte-additives business
Mapped in 1 theme: Electronic Components (ECMS).
Where Acutaas Chemicals sits in the supply chain
Acutaas Chemicals appears in 1 supply-chain layer in one theme, Electronic Components (ECMS).
Electronic Components (ECMS) › Li-ion cells & battery chemicals
Emerging entrantOther companies in this layer
Revenue and profit
| ₹ Cr | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | 717 | 1,007 | 1,339 |
| Net profit | 49 | 160 | 356 |
Latest-year revenue ₹1,339 Cr (FY26, company-wide). Wider screens show FY22 onwards.
Strengths
- ECMS approval (17 Aug 2026) for its electrolyte additives plant at Jhagadia: ₹119 Cr eligible investment, incentive up to 25% through FY31
- Battery chemicals already in commercial supply (per PL, Jul 2026)
- High ROCE and FY26 profit more than doubled
Risks
- Valuation already prices in battery growth
- Battery-chemicals demand depends on global cell makers' qualification cycles
Common questions
What does Acutaas Chemicals do?
Gujarat specialty chemicals company (pharma intermediates, CDMO) with a fast-growing battery-electrolyte-additives business.
Where does Acutaas Chemicals sit in the supply chain?
Acutaas Chemicals (NSE: ACUTAAS) is mapped in 1 supply-chain layer: Li-ion cells & battery chemicals (Electronic Components (ECMS)).
Who are Acutaas Chemicals' peers?
In the Li-ion cells & battery chemicals layer of Electronic Components (ECMS): ATL Battery Technology (India) (not NSE-listed) and PCBL Chemical.
What is Acutaas Chemicals' market cap and valuation?
As of 30 Oct 2026: market cap ₹32,738 Cr, P/E 74.6x, ROCE 31.6%, ROE 24.0%, dividend yield 0.06%.